Cargando…

TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity

BACKGROUND: Tissue factor (TF) pathway inhibitor-1 (TFPI) is expressed in several malignant tissues- and cell lines and we recently reported that it possesses anti-tumor effects in breast cancer cells, indicating a biological role of TFPI in cancer. The two main splice variants of TFPI; TFPIα and TF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stavik, Benedicte, Tinholt, Mari, Sletten, Marit, Skretting, Grethe, Sandset, Per Morten, Iversen, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556101/ https://www.ncbi.nlm.nih.gov/pubmed/23320987 http://dx.doi.org/10.1186/1756-8722-6-5

Ejemplares similares

Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells
por: Andresen, Marianne S., et al.
Publicado: (2020)

Syndecan-3 and TFPI Colocalize on the Surface of Endothelial-, Smooth Muscle-, and Cancer Cells
por: Tinholt, Mari, et al.
Publicado: (2015)

Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility
por: Stavik, Benedicte, et al.
Publicado: (2011)

TFPI Alpha and Beta Regulate mRNAs and microRNAs Involved in Cancer Biology and in the Immune System in Breast Cancer Cells
por: Stavik, Benedicte, et al.
Publicado: (2012)

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
por: Tinholt, Mari, et al.
Publicado: (2015)

Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
por: Tinholt, Mari, et al.
Publicado: (2020)

Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5’-Flanking Region
por: Ali, Huda Omar, et al.
Publicado: (2016)

Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
por: Opstad, Trine B, et al.
Publicado: (2010)

Expression analysis of tissue factor pathway inhibitors TFPI-1 and TFPI-2 in Paralichthys olivaceus and antibacterial and anticancer activity of derived peptides
por: Wang, Guanghua, et al.
Publicado: (2021)

ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI
por: Shi, Qi, et al.
Publicado: (2022)

The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer
por: Hu, Haochang, et al.
Publicado: (2017)

TFPI-2 Protects Against Gram-Negative Bacterial Infection
por: Ali, Mohamad N., et al.
Publicado: (2018)

Association study to evaluate TFPI gene in CAD in Han Chinese
por: Zhao, Ying, et al.
Publicado: (2017)

Two ways of epigenetic silencing of TFPI2 in cervical cancer
por: Fullár, Alexandra, et al.
Publicado: (2020)

TFPI2 Promotes Perivascular Migration in an Angiotropism Model of Melanoma
por: Mo, Jing, et al.
Publicado: (2021)

Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use
por: Winckers, Kristien, et al.
Publicado: (2017)

Factor V‐short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors
por: Dahlbäck, Björn, et al.
Publicado: (2017)

The chemical chaperone sodium 4-phenylbutyrate improves the secretion of the protein C(A267T) mutant in CHO-K1 cells trough the GRASP55 pathway
por: Chollet, Maria Eugenia, et al.
Publicado: (2015)

A hydrophobic patch (PLVIVG; 1481–1486) in the B‐domain of factor V‐short is crucial for its synergistic TFPIα‐cofactor activity with protein S and for the formation of the FXa‐inhibitory complex comprising FV‐short, TFPIα, and protein S
por: Dahlbäck, Björn, et al.
Publicado: (2022)

Protein C Mutation (A267T) Results in ER Retention and Unfolded Protein Response Activation
por: Tjeldhorn, Lena, et al.
Publicado: (2011)

Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport
por: Tjeldhorn, Lena, et al.
Publicado: (2010)

TFPI2 suppresses breast cancer progression through inhibiting TWIST-integrin α5 pathway
por: Zhao, Danyi, et al.
Publicado: (2020)

Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα
por: Ayombil, Francis, et al.
Publicado: (2022)

Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2014)

Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1α
por: Arnason, Terra, et al.
Publicado: (2015)

Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding
por: Petrillo, Teodolinda, et al.
Publicado: (2021)

Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues
por: Kempaiah, Prakasha, et al.
Publicado: (2007)

Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer
por: Xu, Cheng, et al.
Publicado: (2013)

The TFPI-2 Derived Peptide EDC34 Improves Outcome of Gram-Negative Sepsis
por: Papareddy, Praveen, et al.
Publicado: (2013)

Protein S K196E mutation reduces its cofactor activity for APC but not for TFPI
por: Maruyama, Keiko, et al.
Publicado: (2018)

MicroRNA-23a acts as an oncogene in pancreatic carcinoma by targeting TFPI-2
por: Wang, Wei, et al.
Publicado: (2020)

Insights into the Functional Role of ADTRP (Androgen-Dependent TFPI-Regulating Protein) in Health and Disease
por: Lupu, Cristina, et al.
Publicado: (2021)

The methylation of SDC2 and TFPI2 defined three methylator phenotypes of colorectal cancer
por: Lei, Ruixue, et al.
Publicado: (2022)

Case Report and Literature Review: Behçet’s Disease With a Novel TFPI Gene Mutation
por: Ma, Jiewen, et al.
Publicado: (2022)

Methylation of SDC2/TFPI2 and Its Diagnostic Value in Colorectal Tumorous Lesions
por: Zhang, Lianglu, et al.
Publicado: (2021)

Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood
por: Gorczyca, Monika E, et al.
Publicado: (2010)

Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer()
por: Lavergne, Marion, et al.
Publicado: (2013)

Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells
por: Wang, Guangli, et al.
Publicado: (2017)

Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab
por: Chowdary, Pratima
Publicado: (2018)

MEG8 regulates Tissue Factor Pathway Inhibitor 2 (TFPI2) expression in the endothelium
por: Kremer, Veerle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q9jmth7k71r88uimd5nksjb19v